You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
5 January 2022
June Raine – chief executive of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) – is now a Dame Commander of the Order of the British Empire (DBE); Nature’s Sunshine Products has appointed two people to its Board of Directors; and Aytu BioPharma has recruited a new chief financia...
1 November 2021
E-cigarettes could soon be licensed as medicines in the UK.
11 October 2021
Consilient Health has switched its Calci-D chewable tablets from prescription-only to pharmacy (P) status in the UK. Calci-D contains a higher dose of vitamin D3 than existing calcium/vitamin D3 medicines with P status.
24 September 2021
The European Union’s Committee for Medicinal Products for Human Use (CHMP) has re-elected Harald Enzmann as chair, France has warned about vitamin D overdoses in infants, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has added a warning about steroid withdrawal reactions to...
17 September 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) wants to hear your views on regulation of medical devices in the UK.
8 September 2021
New Zealand's Medicines Classification Committee (MCC) is set to reconsider an application to change the status of allopurinol for preventing gout, Europe’s Pharmacovigilance Risk Assessment Committee (PRAC) has extended the mandate of its vice chair for a further three years, and the UK’s Medicines...
19 August 2021
Reckitt’s Nuromol has become the first combination medicine containing ibuprofen and paracetamol to be allowed on general sale outside pharmacies in the UK. The company has been awarded one year of data exclusivity for studies carried out to support the switch from pharmacy (P) to general-sale list...
9 July 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two oral contraceptive pills – HRA Pharma’s Hana and Maxwellia’s Lovima – to be sold without a prescription. Michelle Riddalls – chief executive officer of the Proprietary Association of Great Britain (PAG...
15 February 2021
Two applications to switch oral contraceptives from prescription-only to pharmacy (POM to P) status in the UK are now out for consultation. If they are approved, then Maxwellia’s Lovima and HRA Pharma’s Hana will become the country’s first OTC oral contraceptive pills.
31 December 2020
Sanofi’s Allevia – containing the antihistamine fexofenadine hydrochloride – has been switched from prescription-only to general sales list (GSL) status in the UK.